奧泰生物 (688606.SS)

48.28 +0.54 (+1.13%) 收市：02:45PM CST

奧泰生物

Building 3, 4, 5
No. 550, Yinhai Street, Baiyang Street Hangzhou Economic and Tech Dev Zone Jianggan District
Hangzhou 310018
China
86 57 1562 07860
https://www.alltests.com.cn

版塊: Healthcare
行業: Medical Instruments & Supplies
全職員工: 1,093

高階主管

名稱	頭銜	支付	行使價	出生年份
Mr. Fei Gao	Chairman & GM	無	無	1974
Ms. Yanping Fu	CFO & Secretary of the Board of Directors	無	無	1978
Mr. Weike Lu	Deputy GM & Director	無	無	1981

截止 為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 CNY。

描述

Hangzhou Alltest Biotech Co., Ltd. engages in the research, development, production, and sale of in vitro diagnostic reagents in China and internationally. The company offers rapid diagnostic reagents, including drug and drug abuse, infectious disease, women's health, tumor marker, and cardiac marker testing products. Its products include COVID-19 antigen and antibody tests; veterinary tests; fluorescence immunoassay tests and analyzers; urine analysis solutions, biochemistry reagents, VTM, blood glucose monitoring systems, and HB hemoglobin test meters. In addition, the company offers SARS-COV-2 RT-qPCR assays, virus specimen stabilizers, and viral DNA/RNA extraction kits; and other test products. Its products are used in clinical testing, on-site testing, personal health management, and other fields. Hangzhou Alltest Biotech Co., Ltd. was founded in 2009 and is based in Hangzhou, China.

公司管治

截至 無 止，奧泰生物 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。